A detailed history of Nikko Asset Management Americas, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 7,733,884 shares of ADPT stock, worth $36.3 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
7,733,884
Previous 6,919,778 11.76%
Holding current value
$36.3 Million
Previous $25 Million 58.08%
% of portfolio
0.46%
Previous 0.29%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$3.37 - $5.12 $2.74 Million - $4.17 Million
814,106 Added 11.76%
7,733,884 $39.6 Million
Q2 2024

Aug 09, 2024

BUY
$2.34 - $3.96 $1.74 Million - $2.94 Million
743,071 Added 12.03%
6,919,778 $25 Million
Q1 2024

May 02, 2024

SELL
$2.88 - $4.8 $964,661 - $1.61 Million
-334,952 Reduced 5.14%
6,176,707 $19.8 Million
Q4 2023

Feb 08, 2024

SELL
$3.46 - $5.33 $205,108 - $315,962
-59,280 Reduced 0.9%
6,511,659 $31.9 Million
Q3 2023

Nov 09, 2023

BUY
$5.07 - $8.44 $947,542 - $1.58 Million
186,892 Added 2.93%
6,570,939 $35.8 Million
Q2 2023

Aug 14, 2023

BUY
$6.19 - $8.78 $6.57 Million - $9.32 Million
1,061,511 Added 19.94%
6,384,047 $42.8 Million
Q1 2023

May 03, 2023

SELL
$7.8 - $10.11 $232,276 - $301,065
-29,779 Reduced 0.56%
5,322,536 $47 Million
Q4 2022

Feb 13, 2023

BUY
$6.26 - $9.34 $3.22 Million - $4.8 Million
514,124 Added 10.63%
5,352,315 $40.9 Million
Q3 2022

Nov 14, 2022

BUY
$6.5 - $12.67 $1.43 Million - $2.78 Million
219,792 Added 4.76%
4,838,191 $33.2 Million
Q2 2022

Aug 04, 2022

BUY
$6.4 - $14.73 $3.06 Million - $7.04 Million
477,621 Added 11.53%
4,618,399 $36.1 Million
Q1 2022

May 06, 2022

BUY
$10.12 - $28.9 $9.92 Million - $28.3 Million
979,855 Added 31.0%
4,140,778 $56.5 Million
Q4 2021

Feb 08, 2022

BUY
$25.17 - $36.85 $28.5 Million - $41.8 Million
1,133,445 Added 55.9%
3,160,923 $87.1 Million
Q3 2021

Nov 09, 2021

BUY
$30.02 - $39.87 $7.36 Million - $9.78 Million
245,259 Added 13.76%
2,027,478 $66.8 Million
Q2 2021

Aug 09, 2021

BUY
$32.22 - $44.59 $44.6 Million - $61.7 Million
1,383,409 Added 346.88%
1,782,219 $71.3 Million
Q1 2021

May 03, 2021

BUY
$37.26 - $67.74 $6.48 Million - $11.8 Million
173,991 Added 77.39%
398,810 $16.1 Million
Q4 2020

Feb 11, 2021

BUY
$45.01 - $65.47 $1.55 Million - $2.25 Million
34,356 Added 18.04%
224,819 $13.3 Million
Q3 2020

Nov 02, 2020

BUY
$35.79 - $48.81 $855,023 - $1.17 Million
23,890 Added 14.34%
190,463 $7.81 Million
Q2 2020

Aug 07, 2020

BUY
$24.95 - $48.38 $4.16 Million - $8.06 Million
166,573 New
166,573 $7.04 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.